MannKind Corporation to Hold 2025 Third Quarter Financial Results Conference Call on November 5, 2025

MannKind (Nasdaq: MNKD) will release its third quarter 2025 financial results before the market opens on November 5, 2025.

Rhea-AI Summary

MannKind (Nasdaq: MNKD) will release its third quarter 2025 financial results before the market opens on November 5, 2025. The company will host a webcast at 9:00 a.m. Eastern Time the same day to discuss results and provide a business update.

Investors can access the live webcast and a replay via the company’s investor website at https://investors.mannkindcorp.com/events-and-presentations; the replay will be available within 24 hours and remain accessible for approximately 90 days.

Argus Oct 30 session

+0.18% close to close Open Argus

Details

News Market Reaction – MNKD

On Oct 30, the first trading day after this news, MNKD closed 0.18% above the previous close.

Data tracked by StockTitan Argus for the Oct 30 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that its third quarter 2025 financial results will be released before the market opens on November 5, 2025.

MannKind will host a webcast beginning at 9 a.m. Eastern Time to discuss the financial results and provide a business update. The webcast will be accessible via a link on MannKind’s website at https://investors.mannkindcorp.com/events-and-presentations. A replay will also be available in the same location within 24 hours following the call and be accessible for approximately 90 days.

About MannKind
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.

Learn more at mannkindcorp.com.

MannKind Contacts:
Investor Relations
Ana Kapor
Email: ir@mnkd.com

Media Relations
Christie Iacangelo
Email: media@mnkd.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will MannKind (MNKD) release Q3 2025 results?

MannKind will release its Q3 2025 financial results before the market opens on November 5, 2025.

What time is the MannKind (MNKD) Q3 2025 results webcast?

The company will host a webcast beginning at 9:00 a.m. Eastern Time on November 5, 2025.

Where can investors watch the MannKind (MNKD) November 5, 2025 webcast?

The live webcast and replay will be available at https://investors.mannkindcorp.com/events-and-presentations.

Will MannKind (MNKD) provide a replay of the Q3 2025 webcast and for how long?

Yes. A replay will be posted within 24 hours and will be accessible for approximately 90 days.

Will MannKind (MNKD) include a business update during the November 5, 2025 call?

Yes. The webcast will discuss the financial results and provide a business update.

How can shareholders access supplemental materials for MannKind (MNKD) Q3 2025 results?

Supplemental materials and the webcast link will be posted on MannKind’s investor events and presentations page at the company website.